Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
1200 participants
OBSERVATIONAL
2026-06-30
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis
NCT04698382
Novel Sepsis Sub-phenotypes Based on Trajectories of Vital Signs
NCT05826223
An Algorithm Driven Sepsis Prediction Biomarker
NCT03015454
Sepsis Pre-Alert Monitoring Intervention: Study to Investigate Targeted Enhanced Monitoring for Sepsis
NCT03473769
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
NCT05229328
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The algorithms will compute the probability of sepsis at periodic intervals and will continue to run on a patient's data until the patient's discharge, death, or upon initiation of intravenous antibiotics (at which point there is an indirect record of clinical suspicion of an infection).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ED Patients
All adult patients presenting to Emergency Departments (ED) in the Emory Healthcare system
Epic Sepsis Model Version - 1
The Epic Sepsis Model (ESM) version 1, a proprietary sepsis prediction model.
Epic Sepsis Model Version - 2
The Epic Sepsis Model (ESM) version 2, a proprietary sepsis prediction model.
Emory Sepsis Model
Emory internal algorithm
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Epic Sepsis Model Version - 1
The Epic Sepsis Model (ESM) version 1, a proprietary sepsis prediction model.
Epic Sepsis Model Version - 2
The Epic Sepsis Model (ESM) version 2, a proprietary sepsis prediction model.
Emory Sepsis Model
Emory internal algorithm
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Emory University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Siva Bhavani
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sivasubramanium Bhavani, MD
Role: PRINCIPAL_INVESTIGATOR
Emory University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emory Midtown Hospital
Atlanta, Georgia, United States
Emory Saint Joseph's Hospital
Atlanta, Georgia, United States
Emory Healthcare System
Atlanta, Georgia, United States
Emory Hospital
Atlanta, Georgia, United States
Emory Decatur Hospital
Decatur, Georgia, United States
Emory Johns Creek Hospital
Johns Creek, Georgia, United States
Emory Hillandale Hospital
Lithonia, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024P008316
Identifier Type: OTHER
Identifier Source: secondary_id
STUDY00005958
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.